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ANNEX 
 
EU Drugs Action Plan (2005-2008) 
 
Introduction 
 
The drugs phenomenon is one of the major concerns of the citizens of Europe and a major threat to 
the security and health of European society. The EU has up to 2 million problem drug users. The 
use of drugs, particularly among young people is at historically high levels. The incidence of 
HIV/AIDS among drug users is causing increasing concern in a series of Member States. The 
importance of taking a strong stance against drugs trafficking at all levels and the need for a trans-
national and coherent approach in combating drugs trafficking has been reflected in the adoption of 
the Framework Decision laying down minimum provisions on the constituent elements of criminal 
acts and penalties in the field of drug trafficking
1
. Given the global nature of the drugs problem, the 
EU takes action by utilising a number of political instruments, such as the dialogue on drugs with 
various regions of the world.  Finding a realistic and effective response to this global problem 
remains a political priority for the European Union. 
 
In December 2004, the European Council endorsed the EU Drug Strategy (2005-2012) which sets 
the framework, objectives and priorities for two consecutive four-year Action Plans to be brought 
forward by the Commission. This Strategy is an integral part of the multi-annual programme "The 
Hague Programme" for strengthening freedom, security and justice in the EU
2
.  
                                                 
1
 OJ L 335 of 11.11.2004; evaluation report to be submitted by the Commission by 12 May 
2009 at the latest in the framework of the EU Action Plan on Drugs 2009-2012. 
2
 Point 2.8 European Union Strategy on Drugs " The European Council underlines the 
importance of addressing the drugs problem in a comprehensive, balanced and 
multidisciplinary approach between the policy of prevention, assistance and rehabilitation of 
drug dependence, the policy of combating illegal drug trafficking and precursors and money 
laundering, including the strengthening of international cooperation. The European Strategy 
on Drugs 2005-2012 will be added to the programme after its adoption by the European 
council in December 2004". 
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The Strategy has a number of major aims: 
 
- to achieve a high level of health protection, well-being and social cohesion by complementing 
the Member States’ action in preventing and reducing drug use, dependence and drug-related 
harms to health and society. 
- with due regard for the EU’s achievements and values in terms of fundamental rights and 
freedoms, to ensure a high level of security for the general public by taking action against 
drugs production, cross-border trafficking in drugs and diversion of precursors and by 
intensifying preventive action against drug-related crime through effective cooperation 
embedded in a joint approach. 
- to strengthen the EU’s coordination mechanisms to ensure that action taken at national, 
regional and international levels is complementary and contributes to the effectiveness of drug 
policies within the EU and in its relations with other international partners. The latter calls for 
a more clearly identifiable European position in international fora such as the UN and its 
specialised agencies, reflecting the EU’s dominant position as a donor in this area. 
 
The Strategy concentrates on the two major dimensions of drugs policy, demand reduction and 
supply reduction. It also covers a number of cross-cutting themes: international cooperation, 
research, information and evaluation. 
 
The Action Plan proposed by the Commission and adopted by the Council with some amendments 
takes account of its Final Evaluation of the EU Drug Strategy and EU Action Plan on Drugs (2000–
2004)
3
. It targets in particular those areas that the evaluation highlighted as needing further 
progress. It reiterates a number of essential objectives that were not reached under the previous 
Action Plan. The Commission has also carried out an initial consultation of civil society on future 
policy through a dedicated web site. Such consultation will be significantly expanded by the 
Commission during the course of the Action Plan to include a wide range of representatives of civil 
society across the EU in a dialogue on how best to deal with drugs issues. 
                                                 
3
  COM (2004) 707 final. 
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In terms of the ultimate goal it should be clearly understood that the Strategy and Action Plan are 
not an end in themselves; even if all the objectives they contain are reached we must conclude that 
they have failed if the result is not a measurable reduction of the drugs problem in our societies. The 
citizens of Europe expect this. The ultimate aim of the Action Plan is to significantly reduce the 
prevalence of drug use among the population and to reduce the social harm and health damage 
caused by the use of and trade in illicit drugs. It aims to provide a framework for a balanced 
approach to reducing both supply and demand through a number of specific actions. 
 
These have been chosen on the basis of the following criteria: 
 
- Actions at EU level must offer clear added value and results must be realistic and measurable. 
- Actions must be cost-effective and contribute directly to the achievement of at least one of the 
goals or priorities set out in the Strategy. 
- The number of actions in each field should be targeted and realistic. 
 
In terms of methodology, the Commission and the Council have designed this Action Plan not as a 
static list of political objectives, but as a dynamic policy instrument. It follows the structure and the 
objectives of the Strategy and focuses on concrete results in specific priority areas. Assessment 
tools and indicators have been introduced for each action. These have been drawn up with the help 
of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol, who 
will help the Commission to keep track of implementation of the Action Plan. On this basis the 
Commission will publish an annual report and, if necessary, propose adjustments. 
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Responsibility for implementation of actions and deadlines are clearly indicated in the Plan. To 
keep implementation on track, targets whose deadlines have passed or are unlikely to be met will be 
subject to recommendations for their implementation or identification of failure to implement. The 
Commission will carry out an impact assessment in 2008 in view of proposing a second Action Plan 
for 2009-2012. A final evaluation of the Strategy and the Action Plans will be carried out by the 
Commission in 2012. These evaluations will go beyond the strict confines of the Action Plan and 
will include, on the basis of the work of the EMCDDA and Europol, a general view of the evolution 
of the drugs situation in Europe. 
 
This Action Plan is ambitious in its objectives but it matches the serious nature of the issues 
confronting EU citizens. It respects the principles of subsidiarity and proportionality and leaves full 
scope for local, regional, national and transnational actions, while at the same time encouraging all 
actors to examine how these actions can be mutually supportive and contribute towards achieving 
the objectives of the EU Drug Strategy. 
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COORDINATION 
Identifiable Result: 
 
Coordination is key to the establishment and conduct of a successful strategy against drugs. EU-level coordination of drugs policy should 
take place through the HDG. The HDG should regularly devote attention to external aspects of drugs policy. The national authorities 
responsible for coordinating drug issues and policies will contribute to the practical implementation of the EU Action Plans within the 
context of the implementation of national programmes. 
 
(Related Strategy priorities 17, 18, 19, 20, 21) 
 
Objective Action Timetable
4
 Responsible Party
5
 Assessment tool/Indicator 
1. Ensure a balanced, 
multidisciplinary 
approach  
Member States, with due regard to their national 
legislation and administrative structures, to adopt 
an overall national strategy and one or several 
action plans on drugs and to ensure that national 
strategies/action plans are in line with the EU 
Strategy/Action Plans 
2007 MS Annual report on national 
strategies/action plan by the 
COM, in cooperation with the 
EMCDDA 
 
 
                                                 
4
 Action to be completed by the end of the year indicated at the latest 
5
 Presidency = PRES  
 Member States = MS 
 Commission = COM 
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2. Effective coordination 
at EU and national level 
Member States and the Commission to have a 
fully operational drugs coordination mechanism 
and to designate a person, department or body to 
act as drugs coordinator  
2007 MS  
COM 
MS to report to the COM on 
existing national coordination 
structures 
 
Annual report on national 
structures by the COM, in 
cooperation with the 
EMCDDA 
 
1. The Commission to issue a Green Paper on 
ways to effectively cooperate with civil society  
2006 
COM 
COM’s Green Paper 3. Strengthen the 
involvement of civil 
society 
2. Member States to give the opportunity to civil 
society to present their opinion  
2007 MS MS report to the HDG by 
2008 
 
1. The HDG to focus its activities on the 
monitoring of the implementation of the EU 
Action Plan 
Ongoing Council COM’s Annual Progress 
Review 
4. Effective coordination 
in the Council 
2. The HDG to be the leading forum in the 
Council for EU coordination on drugs. Effective 
coordination between it and other Council 
Working Parties dealing with drug issues, 
including external relations (e.g. Police 
cooperation WG, customs cooperation WG, 
Multidisciplinary Group on organised crime, 
Public health WG, etc.) 
Ongoing PRES 
 
Council 
Report of other Council 
working groups (or the 
PRES) to the HDG on drug 
related issues 
 
Results of the HDG 
discussions on external 
relations drug issues reported 
to the relevant working 
groups and vice-versa 
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1. Ensure that EU action plans for various regions 
are only adopted if adequate resources for their 
implementation are allocated 
 
Ongoing Council COM Report by 2008 5. Systematic 
mainstreaming of drugs 
policy into relations and 
agreements with 
relevant third countries 
 
2. Include a specific provision on drugs 
cooperation in new agreements with third 
countries/regions. HDG should be informed of 
the opening of relevant negotiations. 
 
Annual Council 
 
COM 
Number of new agreements 
with a specific provision on 
drugs 
6. Maintain regular 
forum for EU 
coordination 
 
The Presidency to provide the opportunity to 
those responsible for drug coordination to meet to 
exchange information on national developments, 
to review the scope for greater cooperation and to 
focus on the implementation of the EU Action 
Plan 
Twice a 
year 
PRES 
 
MS  
 
COM 
Outcome of meetings 
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DEMAND REDUCTION 
Identifiable Result: 
Measurable reduction of the use of drugs, of dependence and of drug-related health and social risks through the development and 
improvement of an effective and integrated comprehensive knowledge-based demand reduction system including prevention, early 
intervention, treatment, harm reduction, rehabilitation and social reintegration measures within the EU Member States. Drug demand 
reduction measures must take into account the health-related and social problems caused by the use of illegal psychoactive substances and 
of poly-drug use in association with legal psychoactive substances such as tobacco, alcohol and medicines.  
(Related to Strategy priorities 23, 24 and 25)  
Objective Action Timetable Responsible Party Assessment tool /Indicator 
7. Improve coverage of, 
access to and 
effectiveness of drug 
demand reduction 
measures 
Improve coverage of, access to, quality and 
evaluation of drug demand reduction programmes 
and ensure effective dissemination of evaluated 
best practices 
 
More effective use and regular updating of the 
EMCDDA based EDDRA (Exchange on Drug 
Demand Reduction Action) and other databases  
2007 MS 
 
EMCDDA 
Quantitative and qualitative 
analysis of access to and 
effectiveness of drug demand 
measures (EMCDDA 
treatment demand indicators, 
EDDRA data analysis). 
 
Drug use and risk perception 
on drugs in the general 
population and school studies 
(EMCDDA) 
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1. Ensure that comprehensive effective and 
evaluated prevention programmes on both licit and 
illicit psychoactive substances, as well as poly-
drug use, are included in school curricula or are 
implemented as widely as possible. 
2007 
 
 
MS 
 
 
Number of MS having 
implemented comprehensive 
effective programmes on 
prevention of psychoactive 
substances in schools; 
percentage of pupils reached
6 
8. Improve access to and 
effectiveness of school-
based prevention 
programmes, in 
accordance with national 
legislation.  
2. Support implementation and development of 
joint prevention programs of public services,  
school communities
 
and relevant NGO's.  
2007 MS Idem 
9. Set up, develop and 
improve selective 
prevention and new 
ways of reaching target 
groups, e.g. by using 
different media and new 
information 
technologies. 
 
Develop and improve prevention programmes for 
selected target groups (e.g. street operators, 
socially disadvantaged groups, socially excluded 
children and families at risk, young people in the 
out of school sector) and specific settings (e.g. 
drugs and driving, drugs in the work place, drugs 
in recreational settings) taking into account gender 
differences.  
2008 
 
 
MS 
COM 
 
Rate of availability of 
prevention programmes for 
specific target groups 
(EMCDDA) 
COM study on the influence 
of alcohol, drugs and 
medicines on driving by 2008 
Number of Member States 
having implemented 
programs in the work place 
 
Number, coverage and 
evaluated effectiveness of 
prevention projects in 
recreational settings 
(EMCDDA) 
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1. Detection of risk factors related to experimental 
use by different target groups, especially by young 
people and the dissemination thereof for the 
benefit of early intervention programmes and the 
training of professionals  
Ongoing MS MS report on risk factors 
related to drug use of the 
different target groups, 
especially by young people  
2. Ensure the provision of training for relevant 
professionals who come into contact with potential 
drug users, especially young people 
 
Ongoing MS MS Report on estimated 
percentage of professionals 
who receive specific training 
by 2008. 
 
Age of first drug use/ first 
treatment demand 
(EMCDDA) 
10. Improve methods for 
early detection of risk 
factors and early 
intervention 
3. Implementation of the early intervention 
programmes, including measures especially related 
to experimental use of psychoactive substances 
Ongoing 
 
MS 
 
Number of early intervention 
programmes implemented 
(EMCDDA) 
 
Estimated population reached 
(EMCDDA) 
1. Evidence based treatment options covering a 
variety of psychosocial and pharmacological 
approaches to be available and correspond to 
demand for treatment 
Ongoing MS Treatment demand and 
availability indicators 
(EMCDDA) 
2. Establish strategies and guidelines for increasing 
availability of and access to services for drug users 
not reached by existing services 
Ongoing MS 
Treatment demand and 
availability indicators 
(EMCDDA) 
11. Ensure the 
availability of and 
access to targeted and 
diversified treatment and 
rehabilitation 
programmes 
3. Improve access to and coverage of rehabilitation 
and social reintegration programmes, paying 
special attention to specialized (social, 
psychological, medical) services for young people 
who use drugs  
Ongoing MS 
Number of people covered by 
these programmes 
(EMCDDA) 
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 4. Organise and promote dissemination of 
information on the availability of treatment and 
rehabilitation programmes 
Ongoing MS 
Number of national and local 
campaigns (EMCDDA) 
12. Improve the quality 
of treatment services 
Support development of know-how on drug 
treatment while continuing to develop and support 
the exchange of best practices in this field 
2008 
Council 
COM 
COM report by 2007 
1. Make effective use and develop further 
alternatives to prison for drug abusers  
Ongoing MS MS Report to the HDG by 
2008 
13. Further develop 
alternatives to 
imprisonment for drug 
abusers and drug 
services for people in 
prisons, with due regard 
to national legislation.  
2. Develop prevention, treatment and harm 
reduction services for people in prison, 
reintegration services on release from prison and 
methods to monitor/analyse drug use among 
prisoners. 
 
Ongoing MS 
COM 
COM proposal for a 
recommendation by 2007 
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14. Prevention of health 
risks related to drug use 
Implementation of the Council Recommendation 
on the prevention and reduction of health related 
harm associated with drug dependence 
Ongoing MS COM report by 2006 
15. Availability and 
access to harm reduction 
services 
Improve access for addicts to all relevant services 
and treatment options designed to reduce harm, in 
due regard with national legislation 
Ongoing MS Treatment demand and 
availability indicators 
(EMCDDA) 
Analysis of different types of 
harm and damage reduction 
services available in the MS 
(EMCDDA) 
16. Prevention of the 
spread of HIV/AIDS, 
hepatitis C, other blood 
born infections and 
diseases 
Ensure the implementation of comprehensive and 
coordinated national and/or regional programmes 
on HIV/AIDS, hepatitis C and other blood born 
diseases. These programmes should be integrated 
into general social and health care services.  
Ongoing 
 
MS 
COM  
Prevalence indicators on 
HIV, hepatitis C and other 
infections (EMCDDA) 
17. Reduction of drug 
related deaths 
Reduction of drug related deaths to be included as 
a specific target at all levels with interventions 
specifically designed for this purpose, such as 
promoting outreach work, e.g. the work of street 
units, through well-trained healthcare operators 
Ongoing MS Drug related deaths indicator 
(EMCDDA 
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SUPPLY REDUCTION 
Identifiable Result: 
A measurable improvement in the effectiveness, efficiency and knowledge base of law enforcement interventions and actions by the EU 
and its Member States targeting production, trafficking of drugs, the diversion of precursors, including the diversion of synthetic drug 
precursors imported into the EU, drug trafficking and the financing of terrorism, money laundering in relation to drug crime.  This is to 
be achieved by focusing on drug-related organised crime, using existing instruments and frameworks, where appropriate opting for 
regional or thematic cooperation and looking for ways of intensifying preventive action in relation to drug-related crime. 
(Related Strategy Priorities 27.1, 27.2, 27.3, and 27.4)  
Objective Action Timetable Responsible 
Party 
Assessment tool /Indicator 
18. Step up and develop 
law enforcement co-
operation between 
Member States and, 
where appropriate, with 
Europol, Eurojust, third 
countries and 
international 
organisations, against 
international organised 
drug production and 
trafficking 
1. Implement:  
- Operational law enforcement projects, such as joint 
investigation teams, joint customs operations and 
joint investigations. 
- Law enforcement intelligence projects to improve 
both the intelligence picture and interventions made. 
These projects should involve at least 2 Member 
States and should be focused on drug production, 
illicit cross-border trafficking and criminal networks 
engaged in these activities. 
Ongoing 
 
 
MS
6
 
 
Europol 
 
Eurojust 
 
Number of operational and 
intelligence law enforcement 
projects initiated or 
completed 
Quantity and value of 
precursors and drugs seized  
Number of criminal groups 
disrupted 
Number of illicit 
laboratories dismantled 
 
                                                 
6
  Relevant data in relation to the assessment tool/indicator to be provided by the lead MS for the project, unless otherwise agreed. 
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 2. Seek to exploit to the full the operational and 
strategic potential of Europol, building on existing 
collaboration between Europol and the Europol 
National Units and improving the intelligence picture 
of supply and distribution, by: 
 
- Member States improving the consistency with 
which relevant live information (information as 
specified in the opening orders of Analysis Work 
Files) on drug trafficking groups and routes is 
forwarded to the agency in accordance with the 
provisions in the Europol Convention for such 
exchange of information; 
 
- Member States improving the consistency with 
which they forward seizure data to Europol; 
 
- Europol ensuring that the accumulated 
information is available for Member States' 
operational and strategic use; 
 
- Europol providing periodic strategic threat 
assessments based on this data; 
 
- Evaluating the success and operational impact 
of the cycle of intelligence gathering, analysis, 
distribution and resulting operational action, and 
seeking the improvements thus revealed. 
Ongoing MS 
 
Europol 
 
Europol reports 
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3. Strengthen controls at the external borders of the 
EU to stem the flow of drugs from third countries. 
 
Ongoing MS Quantity and value of drugs 
and precursors seized at the 
external borders 
Member States reports on 
actions taken by services on 
strengthening controls at 
external borders  
4. Carry out specific actions in the fight against 
cross-border drug trafficking inside the EU. 
 
Ongoing MS Member States reports on 
specific actions taken 
 
5. Assess the feasibility of developing a strategy for 
the use of heroin and cocaine forensic profiling 
results for law enforcement strategic and operational 
purposes and make recommendations regarding 
same. 
2006 MS Feasibility report including 
recommendations completed  
19. Reduce the 
production and cross-
border trafficking of 
heroin, cocaine and 
cannabis 
 
Implement joint multidisciplinary operational and 
intelligence gathering projects, share best practice, 
and increase counter narcotics work. Focus this work 
on external countries and regions associated with the 
production of and cross-border trafficking in heroin, 
cocaine and cannabis into the EU. 
Ongoing MS 
Europol 
Number of operations 
initiated or completed 
Quantity and value of heroin 
cocaine and cannabis seized 
Number of criminal groups 
disrupted 
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1. Develop operations and intelligence gathering 
projects to prevent and combat synthetic drug 
manufacture and trafficking. These operations should 
involve at least 2 Member States. In this regard full 
use should be made of the SYNERGY Project.  
Ongoing 
 
MS
7
 
Europol 
 
Number of operations and 
intelligence gathering 
projects initiated or 
completed 
Quantity and value of 
synthetic drugs and 
synthetic drug precursors 
seized 
Number of criminal groups 
disrupted 
Number of illicit 
laboratories dismantled 
20. Reduce the 
manufacture and supply 
of synthetic drugs (ATS) 
2. Develop a long term solution at EU level for the 
use of synthetic drug forensic profiling results for 
law enforcement strategic and operational purposes. 
The development of such a solution should be done 
by law enforcement agencies and forensic authorities 
working together and building upon experiences in 
this field 
2008 
 
MS 
COM 
Europol 
Report on the development 
of a long term solution
8
 
 
                                                 
7
  Relevant data in relation to the assessment tool/indicator to be provided by the lead MS for the project, unless otherwise agreed. 
8
  MS report in co-operation with the Commission and Europol. 
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 3. Implement fully the Council Decision on 
information exchange, risk assessment and control of 
new psychoactive substances 
Ongoing 
Council  
MS 
COM 
Europol 
EMCDDA 
European 
Medicines Agency 
Europol/EMCDDA annual 
report to the Council, 
European Parliament and the 
Commission 
 
21. Combat serious 
criminal activity in the 
field of chemical 
precursor diversion and 
smuggling by stepping 
up law enforcement 
cooperation between 
Member States and, as 
appropriate, with 
Europol, Eurojust, third 
countries and 
international 
organisations 
Implement law enforcement projects such as the 
European Joint Unit on Precursors. These projects 
should involve at least 2 Member States 
 
Ongoing MS
9
 
Europol 
Eurojust 
 
Number of law enforcement 
projects initiated or 
completed 
Quantity and value of 
precursors and drugs seized 
Number of criminal groups 
disrupted 
                                                 
9
  Relevant data in relation to the assessment tool/indicator to be provided by the lead MS for the project, unless otherwise agreed. 
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1. Implement the Community drug precursor 
legislation, in particular the cooperation between MS 
in relation to controls of imports of synthetic drug 
precursors. Strengthen external border controls by 
customs or other competent authorities and 
strengthening intra-Community controls. 
Ongoing MS
10
 
COM 
Number of seizures/stopped 
shipments 
2. Support international operations of the UN INCB 
(International Narcotics Control Board), in particular 
Project Prism 
Ongoing MS 
COM 
Europol 
Number of seizures/stopped 
shipments 
22. Prevent the diversion 
of precursors, in 
particular synthetic drug 
precursors imported into 
the EU  
3. Develop co-operation between Member States’ 
authorities competent for precursor control and 
Industry 
Ongoing 
MS 
COM 
Number of Memoranda of 
Understanding/similar 
arrangements with Industry 
and/or Number of seminars 
with Industry 
Number of notifications and 
number of investigations 
resulting from this 
                                                 
10
  Relevant data in relation to the assessment tool/indicator to be provided by the Member States. 
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1. Implement operational law enforcement projects 
such as  
(i) projects to pursue drug trafficking organisations 
including concurrent and in depth investigation of the 
criminals’ finances and assets (of whatever kind) 
aimed at maximising recovery of assets and the 
compilation/sharing of associated intelligence; 
and 
(ii) projects aimed at detecting and disrupting 
criminal cash flows within the EU and from the EU 
to specific high-risk destinations outside the EU and 
source countries. 
These operational law enforcement projects should 
involve at least 2 Member States 
Ongoing MS
11
 
Europol 
Eurojust 
Number of operational law 
enforcement projects 
initiated or completed 
Seizure of cash and assets 
seized as a result of drug 
related investigations 
Value of assets recovered 
and confiscated relative to 
the number of operational 
law enforcement projects 
completed 
2. Develop co-operation in the exchange of 
information between Financial Intelligence Units 
(FIUs) by utilising FIU-Net as a means of 
exchanging information between them 
2006 MS 
Number of MS using FIU-
Net 
3. Consider the possibility of creating national 
multidisciplinary Units for the detection and 
investigation of criminals’ finances and  assets 
2008 MS 
COM 
COM report on the creation 
of such Units 
23. Target money 
laundering and seizure 
of accumulated assets in 
relation to drug crime 
4. Identify and evaluate best practice in criminal 
asset confiscation legislation and procedures of the 
Member States taking into account all relevant EU 
instruments 
2007  COM 
 
                                                 
11
  Relevant data in relation to the assessment tool/indicator to be provided by the lead MS for the project, unless otherwise agreed. 
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 5. Explore best practice in Member States which 
have established and implemented a national fund 
used to provide funding for projects in the drugs field 
and financed from the confiscation of assets earned 
through drug production and trafficking.   
2007 COM 
Study on best practices in 
MS which have established 
and implemented such a 
fund.  
24. Explore possible 
links between drug 
production and 
trafficking and financing 
of terrorism 
Identify possible links between drug production and 
trafficking and financing of terrorism and use this 
information to support or initiate investigations 
and/or actions 
2007 COM 
Europol  
MS 
Number of investigations 
and/or actions initiated or 
completed 
1. Adopting a common definition of the term "drug-
related crime" 
2007 Council  
Commission 
Commission proposal on the 
basis of the existing studies 
to be brought forward by the 
EMCDDA 
2. Share experiences and best practices in preventing 
the distribution of drugs at street level and present 
the results 
2007 MS 
Council 
Results presented 
25. Step up work on 
prevention of drug 
related crime 
3. Conduct a study on drug related crime prevention 
practices in third countries 
2008 COM Study completed 
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26. Develop new 
methods and best 
practice to combat drug-
related crimes and to 
prevent the diversion of 
precursors committed 
with the aid of 
information technology 
MS to collect data on drug-related crime and 
precursor diversion committed with the aid of 
information technology with a view to developing 
new methods and best practice to combat these 
phenomena 
2008 
MS 
Council 
Results presented 
27. Increase training for 
law enforcement 
agencies  
MS and CEPOL, within their respective 
competences, to include in their annual work 
(training) programmes more training courses for law 
enforcement officers specifically relating to 
combating drug production and trafficking 
2006 
MS 
 
CEPOL 
Additional relevant training 
included in the respective 
Annual Work Programmes  
  
8652/1/05 REV 1  JV/mp 23 
ANNEX DG H II    EN 
 
INTERNATIONAL COOPERATION 
Identifiable Result: 
 
A measurable improvement in effective and more visible coordination between Member States and between them and the Commission in 
promoting and furthering a balanced approach to the drugs and precursor problem in dealings with international organisations, in 
international fora and with third countries.  This with the aim to reduce the production and drugs supply to Europe and to assist third 
countries in priority areas in reducing the demand for drugs as an integral part of political and development cooperation.  
 
(Related Strategy Priorities 27.5, 30.1, 30.2, and 30.3) 
Objective Action Timetable Responsible Party Assessment tool /Indicator 
28. Adopt EU common 
positions on drugs in 
international fora  
EU positions at international meetings dealing with 
drugs issues to be prepared in the HDG and other 
co-ordination fora. EU coordination meetings to 
take place during Commission on Narcotic Drugs 
(CND) and other meetings 
Ongoing PRES 
MS 
COM 
Number of EU positions for 
relevant international 
meetings in relation to the 
number of national positions 
29. Articulate and 
promote the EU 
approach on drugs 
The Presidency and/or Commission to take the 
lead role in articulating and promoting the EU’s 
balanced approach 
Ongoing PRES 
MS 
COM 
Number of EU statements in 
relation to the number of 
national statements 
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30. Bring forward EU 
joint resolutions and to 
co-sponsor other 
resolutions  
At the UN, in particular the CND, the Presidency 
to endeavour to have resolutions brought forward 
as EU joint resolutions and/or EU co-sponsoring of 
other resolutions  
Ongoing PRES 
MS 
COM 
Number of EU joint 
resolutions and co-
sponsored resolutions in 
relation to the total number 
of resolutions 
Convergence Indicator (see 
doc. 9099/05 
CORDROGUE 27) 
1. Take an initiative to propose common EU 
criteria, in the framework of the Commission on 
Narcotic Drugs, for the final evaluation of the 
implementation of the Political Declaration, the 
Declaration on the guiding principles of drug 
demand reduction and the Measures to enhance 
international co-operation to counter the world 
drug problem adopted at UNGASS 1998 
2006  COM 
Council 
PRES 
MS 
EU proposal for CND 2006 
on the basis of a 
Commission initiative 
31. Formulate an EU 
contribution to the final 
evaluation of the 
implementation of the 
results of the 1998 UN 
General Assembly 
Special Session on 
Drugs (UNGASS)  
2. Develop an EU common position on the results 
of the final evaluation of the implementation of the 
Political Declaration, the Declaration on the 
guiding principles of drug demand reduction and 
the Measures to enhance international co-operation 
to counter the world drug problem adopted at 
UNGASS 1998 
2008 COM 
Council 
PRES 
MS 
EU common position on the 
basis of a Commission 
initiative 
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32. Support the 
candidate and 
stabilisation and 
association process 
countries 
 
Provide the necessary technical and other assistance 
to these countries to familiarise them with the EU 
acquis and to assist them in carrying out the 
required actions 
2008 MS 
COM 
EMCDDA 
Europol 
Number of projects 
completed; expenditure and 
percentage of total 
expenditure on assistance to 
these countries 
33. Enable candidate 
countries to participate 
in the work of 
EMCDDA, Europol 
and Eurojust 
12
 
 
Conclude agreements with candidate countries 2008  Council  
COM 
Number of cooperation 
agreements concluded 
1. Implement drugs sections of European 
Neighbourhood Policy Action Plans 
 
2008 MS 
COM 
Number of drugs provisions 
implemented 
34. Assist European 
neighbours  
2. Implement drugs section of the EU-Russia Action 
Plan against organised crime and of the Roadmap to 
the Common Space of Freedom, Security and 
Justice; explore scope for enhanced action with 
Russia, especially in this roadmap, and other 
neighbouring countries to reduce the drug-related 
risk  
 
2006 MS 
COM 
Number of drugs provisions 
implemented 
 
                                                 
12
  Eurojust to co-operate with the candidate countries through nomination of contact points and consideration of co-operation agreements in line 
with the Council conclusions on Eurojust of 2.12.2004. 
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35. Ensure that the 
drugs concerns are 
taken on board when 
establishing priorities 
in the EU’s cooperation 
with third 
countries/regions 
Mainstream projects in the drugs field into the EU’s 
cooperation with third countries/regions, especially 
those affected by drug problems. Particular attention 
should be paid to providing assistance to and co-
operating with: 
- the countries on the Eastern border of the EU  
- the Balkan States 
- Afghanistan (particularly in  the context of the 
delivery of its 2005 Counter-Narcotics 
Implementation Plan and future implementation 
plans) and its neighbours; the EU and Member 
States should aim to increase their assistance 
- the Latin American and Caribbean countries 
- Morocco 
- countries on other drug routes 
This assistance and co-operation to be linked to the 
drugs action plans adopted by the EU with various 
regions and the drug sections of other action plans 
with EU partners, where applicable. 
2008 MS 
COM 
 
Number of projects 
completed; expenditure and 
percentage of total 
expenditure on assistance to 
these countries/regions 
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1. Create and/or further develop MS liaison 
officers’ networks. Each network to meet, at least 
on a six monthly basis, to improve operational 
cooperation and coordination of MS action in third 
countries 
Ongoing MS Number of MS liaison 
officer networks created 
and/or further developed. 
Number of meetings held 
2. Provide relevant training to MS liaison officers Ongoing MS Training for MS liaison 
officers provided in MS 
Annual (training) Work 
Programmes 
3. Implement or support, as appropriate, operational 
law enforcement projects, share best practice and 
increase counter narcotics work in the 
countries/regions listed in Action 35  
 
Ongoing MS Number of operational law 
enforcement projects 
initiated or completed 
Quantity and value of 
precursors and drugs seized  
Number of criminal groups 
disrupted 
Number of illicit 
laboratories dismantled 
36. Intensify law 
enforcement efforts 
directed at non-EU 
countries, especially 
producer countries and 
regions along 
trafficking routes 
4. Provide assistance to the law enforcement 
agencies of the countries/regions listed in Action 
35, in the field of counteracting the production and 
trafficking of drugs and diversion of precursors. 
This assistance should include assistance in the field 
of training 
Ongoing MS 
COM 
Number of law enforcement 
drugs projects completed 
Expenditure on law 
enforcement drugs projects 
  
8652/1/05 REV 1  JV/mp 28 
ANNEX DG H II    EN 
1. Use mechanisms, such as the Coordination and 
Cooperation Mechanism on Drugs between the 
EU/Latin America and the Caribbean, UE 
specialized dialogue on drugs with the Andean 
community and Drug Troika meetings to pursue an 
active political dialogue with the countries and 
regions concerned  
Ongoing Council 
COM 
Annual report on the use of 
these mechanisms 
2. Review the activities and measures and, where 
appropriate, establish new priorities in the drugs 
action plans the EU has adopted with: 
- Latin America and the Caribbean 
- Central Asia 
- Western Balkan countries 
 
 
2006 
2007 
2008 
Council 
COM 
 
Review reports 
3. Participate fully in the work of international 
organisations and fora concerned with the drugs 
problem, such as the Council of Europe (Pompidou 
Group), UNODC, WHO and UNAIDS 
Ongoing Council 
MS 
COM 
Report on EU activities 
within these organisations 
and fora 
37. Continue and 
develop an active 
political engagement by 
the EU with third 
countries/regions  
4. Utilise fully the Dublin Group as a flexible, 
informal consultation and co-ordination mechanism 
for global, regional and country-specific problems 
of illicit drugs production, trafficking and demand 
Ongoing Council 
MS 
Commission 
Report on EU activities 
within the Dublin Group 
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 5. Maintain an active dialogue with third countries 
for the implementation of Mini Dublin Groups’ 
recommendations 
 
Ongoing Council 
Dublin Group 
Number of Dublin Group 
recommendations 
implemented
13
 
1. Exchange information on drug related technical 
assistance projects and operational activities in 
candidate countries and third countries/regions, in 
particular to identify duplication and gaps in 
technical assistance and operational activities 
Annual Council 
COM 
Annual report by COM to 
the Council 
Update of the database on 
technical assistance projects 
in candidate and third 
countries by COM on the 
basis of information 
provided by MS.  
38. Improve the 
coherence, visibility 
and efficiency of the 
assistance to candidate 
countries and third 
countries/regions  
2. Evaluate EC and Member States drug projects 
included in cooperation programmes 
2008 MS 
COM 
MS and COM reports to the 
Council 
                                                 
13
  The Dublin Group comprises the EU Member States/European Commission and five other countries. The EU Member States/European 
Commission do not therefore have exclusive ownership of their recommendations.  
  
8652/1/05 REV 1  JV/mp 30 
ANNEX DG H II    EN 
 
INFORMATION, RESEARCH AND EVALUATION 
Identifiable Results: 
(a) A better understanding of the drugs problem and the development of an optimal response to it through a measurable and sustainable 
improvement in the knowledge base and knowledge infrastructure. 
(b) To give clear indications about the merits and shortcomings of current actions and activities on EU level, evaluation should continue to 
be an integral part of an EU approach to drugs policy. 
(Related to Strategy priorities 31, 32) 
Objective Action Timetable Responsible Party Assessment tool /Indicator 
39. Provide reliable and 
comparable data on key 
epidemiological 
indicators 
Full implementation of the five key 
epidemiological indicators and, as appropriate, fine 
tuning of these indicators  
2008 MS 
EMCDDA 
Reports from the MS 
identifying possible problems 
in implementation 
1.  REITOX National Focal Points and Europol 
National Drugs Units to pursue their work to 
ensure their annual and standardised reporting on 
national drugs situations 
Annual MS Reports delivered 40. Provide reliable 
information on the drug 
situation 
2. EMCDDA and Europol to pursue annual 
reporting on the drug phenomenon at EU scale 
Annual EMCDDA 
Europol 
Reports delivered 
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1.Achieve an agreement on EU guidelines and 
mechanisms on detecting, monitoring and 
responding to emerging trends 
2008 Council 
COM 
COM Proposal by 2007 in 
cooperation with the 
EMCDDA and Europol 
41. Develop clear 
information on emerging 
trends and patterns of 
drug use and drug 
markets 2. The Commission to provide for a Eurobarometer 
survey on youth attitude regarding drugs. The 
results of the Eurobarometer should be analysed in 
conjunction with the data from the EMCDDA 
"Population survey" key indicator  
2008 COM Report delivered 
42. Produce estimates on 
public expenditure on 
drug issues 
Member States and Commission to consider the 
development of compatible methodologies on 
direct and indirect expenditure on drug-related 
measures, with the support of the EMCDDA 
2008 MS 
COM 
EMCDDA 
Report based on this 
methodology 
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1. Promote research in the context of the 
Community Programme for Research and 
Development and of Member States research 
programmes   
 
- on biomedical, psychosocial and other factors 
contributing to drug use and addiction and  
 
- on other relevant issues, such as the effectiveness 
of primary awareness campaigns, effective 
interventions to prevent HIV/Aids and hepatitis C 
and the long term effects of Ecstasy use 
Ongoing MS 
COM 
Identification and inclusion of 
topics in the Framework 
Programme and the work 
programmes as well as 
national research programmes 
Amount of successful drug 
related applications to the 
Research Programme and 
number of projects supported 
at the MS level 
2. Promote research on identifying protective 
factors in countries with low HIV/AIDS 
prevalence rates in drug users. 
2007 MS  
with the support of 
EMCDDA 
Study delivered 
43. Promote research in 
the field of drugs  
3. Make full use of the research capacity of the 
Council of Europe (Pompidou Group) 
Ongoing MS 
COM 
Report on research activities 
of the Pompidou Group 
44. To create networks 
of excellence in drug 
research 
Encourage research networks, universities and 
professionals to develop/create networks of 
excellence for the optimal use of resources and 
effective dissemination of results 
 
2007 COM COM report on the level of 
networking and acquired 
funding for these networks 
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1. Establish a consolidated list of indicators and 
assessment tools for the evaluation of the EU Drug 
Strategy and Action Plans  
Ongoing COM 
EMCDDA 
Europol 
COM Annual review with the 
support of the EMCDDA and 
Europol 
2. Commission to present progress reviews to the 
Council and the European Parliament on the 
implementation of the Action Plan and proposals 
to deal with identified gaps and possible new 
challenges 
Annual COM COM Annual review with the 
support of EMCDDA and 
Europol 
45. Continuous and 
overall evaluation  
3. Commission to organise an impact assessment 
with a view of proposing a new Action Plan for 
2009 – 2012 
2008 COM Impact assessment with the 
support of EMCDDA and 
Europol 
46. Follow up of the 
mutual evaluation of 
drug law enforcement 
systems in the Member 
States 
Extent of implementation of recommendations for 
best practices  
2006 Council Council report and proposal 
for recommendations 
 
 
 
 
________________________ 
 
